Special committee report, Part II: Quantitative evaluation of chemicals that induce aneuploidy using the genetic activity profile method.
D000782:Aneuploidy; D000818:Animals; D002478:Cells, Cultured; D004330:Drosophila / Q000187:drug effects / Q000235:genetics; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D005658:Fungi / Q000187:drug effects; D006801:Humans; D008297:Male; D009152:Mutagenicity Tests / Q000379:methods; D009153:Mutagens / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology / Q000187:drug effects; D010944:Plants / Q000187:drug effects / Q000235:genetics; D013094:Spermatozoa / Q000166:cytology / Q000187:drug effects; D013723:Teratogens
D009153:Mutagens; D013723:Teratogens